In particular, the absence of ATRX mutations contrasts with its well-documented role in lower-grade gliomas and astrocytomas, implying that alternative mechanisms, such as chromatin remodeling defects, might be involved in tumor progression [18]. The gene discussed is ATRX; the disease is astrocytoma (excluding glioblastoma).